Baduanjin Lower Elevated Blood PreSsure Study

Launched by CHINA NATIONAL CENTER FOR CARDIOVASCULAR DISEASES · May 25, 2022

Keywords

ClinConnect Summary

The Baduanjin Lower Elevated Blood Pressure Study is looking at how a traditional exercise practice called Baduanjin can help people with slightly high blood pressure, known as high normal blood pressure. This trial aims to see if Baduanjin can not only lower blood pressure but also improve overall health by affecting blood sugar levels, cholesterol, quality of life, mental well-being, physical fitness, and the health of blood vessels.

To participate, you need to be at least 40 years old and have a systolic blood pressure (the top number) between 130 and 139 mmHg or a diastolic blood pressure (the bottom number) between 85 and 89 mmHg. However, if you have been diagnosed with high blood pressure or certain medical conditions like heart disease or kidney disease, you won't be eligible. Participants can expect to engage in Baduanjin exercises and will be monitored throughout the study. It's also important to note that those who regularly exercise or who have recently taken specific medications may not qualify. This study is currently recruiting participants of all genders, and it represents a great opportunity to explore a natural way to manage blood pressure and enhance well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 40 years or older;
• • Systolic blood pressure (SBP) \<140 mmHg and diastolic blood pressure (DBP) \<90 mmHg
• • SBP 130-139 mmHg, and/or DBP 85-89 mmHg
• Exclusion Criteria:
• • Diagnosis of hypertension (SBP≥140 mmHg, and/or DBP ≥90mmHg）
• • History of cardiovascular diseases, such as coronary heart disease, heart failure, stroke, and peripheral vascular disease
• • Diagnosis of chronic kidney disease, primary aldosteronism, Cushing's syndrome, or pheochromocytoma
• • Newly diagnosed cancer or cancer metastasis within 5 years
• • History of autoimmune disease
• • Having taken antihypertensive drugs or immunoregulators within 2 weeks
• • A long-term need for antihypertensive drugs or immunomoregulators
• • Unable to maintain moderate intensity exercise due to illness or other reasons
• • Pregnant, breastfeeding, or planning to become pregnant within the next 1 year
• • Currently taking regular exercise (at least 30 minutes of moderate-intensity exercise at least three times a week)
• • Allergic to sports bracelets
• • Having participated or been participating in other clinical trials within the last 3 months
• • Unable to use smartphones
• • Other factors that may affect the follow-up, such as alcohol or substance abuse in the last 12 months, planing to live out of town for a long time, or diagnosis of dementia or cognitive impairment which indicates incapability of completing the study
• • Unable to accurately measure blood pressure using the sphygmomanometer provided by the study due to a too large or too small arm circumference